Author Correction: The role of IGF2BP3/SPOP/c-Myc loop in paclitaxel resistance of endometrial cancer

Author Correction: The role of IGF2BP3/SPOP/c-Myc loop in paclitaxel resistance of endometrial cancer

Saved in:

Bibliographic Details
Main Authors:	Yidong Ge, Lili Kong, Yuxuan Li, Zongdong Yu, Fengguang Zhai, Ziqing Zhan, Gun Chen, Shuyan Wang, Haoyun Wang, Yuxuan Wang, Jianan Zhao, Lechen Hu, Jianing Mao, Siyuan Wang, Jiaxin Shi, Mengxiang Zhao, Pengrong Lou, Meng Ye, Xiaofeng Jin
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-07-01
Series:	Communications Biology
Online Access:	https://doi.org/10.1038/s42003-025-08406-z
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The role of IGF2BP3/SPOP/c-Myc loop in paclitaxel resistance of endometrial cancer
by: Yidong Ge, et al.
Published: (2025-04-01)

LMNB2-mediated high PD-L1 transcription triggers the immune escape of hepatocellular carcinoma
by: Yuxuan Li, et al.
Published: (2025-06-01)

Retracted: SPOP Inhibition of Endometrial Carcinoma and Its Clinicopathological Relationship
by: Applied Bionics and Biomechanics
Published: (2023-01-01)

SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions
by: Qiwei Jiang, et al.
Published: (2021-08-01)

IGF2BP3-mediated m6A modification of RASGRF1 promoting joint injury in rheumatoid arthritis
by: Qishun Geng, et al.
Published: (2025-05-01)

The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer
by: Yuqian Yan, et al.
Published: (2019-09-01)

Correction: SPOP‑mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions
by: Qiwei Jiang, et al.
Published: (2025-05-01)

RETRACTED ARTICLE: Long non-coding RNA 91H regulates IGF2 expression by interacting with IGF2BP2 and promotes tumorigenesis in colorectal cancer
by: Tianyi Gao, et al.
Published: (2020-01-01)

IGF2BP3 as a Novel Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma
by: Feiming Hu, et al.
Published: (2025-08-01)

Zmiany w stężeniach insulinopodobnych czynników wzrostu IGF-1 i IGF-2 i białek wiążących BP-2 i BP-3 w czasie leczenia ostrej białaczki limfoblastycznej
by: Maryna Krawczuk-Rybak, et al.
Published: (2004-03-01)

The role of IGF2BP2 in macrophage-mediated NLRP3 inflammasome activation in the pathogenesis of dry AMD
by: Yuqing Zhao, et al.
Published: (2025-04-01)

Zbtb16 determines the fate plasticity of cardiovascular progenitors through IGF2BP3-mediated mRNA stabilization
by: Wuchan Wang, et al.
Published: (2025-08-01)

Mechanism of IGF2BP2 regulation of PPAR-γ/GLUT4 pathway in insulin resistance induced by sodium arsenite exposure in HepG2 cells
by: Shiqing XU, et al.
Published: (2025-04-01)

IGF2BP3 prefers to regulate alternative splicing of genes associated with the progression of gastric cancer in AGS cells
by: Xiangyue Zeng, et al.
Published: (2025-02-01)

IGF2BP3 As a Prognostic Biomarker and Regulator of Metastasis in Merkel Cell Carcinoma
by: Yajie Yang, et al.
Published: (2025-05-01)

CircRNA aptamer targets IGF2BP2 to overcome acquired BETi resistance
by: Christophe Nicot
Published: (2025-08-01)

Knockdown of IGF2BP2 overcomes cisplatin-resistance in lung cancer through downregulating Spon2 gene
by: Shilei Zhang, et al.
Published: (2024-12-01)

Circ_0006646 Promotes the Progression of Osteoarthritis via Upregulating CDH11 Expression in an IGF2BP2‐Dependent Manner
by: Ming‐Yu Hua, et al.
Published: (2025-08-01)

Updates on SPOP Gene Mutations in Prostate Cancer and Computational Insights From TCGA cBioPortal Database
by: Suleiman Zakari, et al.
Published: (2025-01-01)

IGF2BP1-mediated methylation of ABCA1 facilitates tumor progression by affecting cholesterol metabolism in lung adenocarcinoma
by: Shaohua Xu, et al.
Published: (2025-08-01)

The miR-6240 target gene Igf2bp3 promotes myoblast fusion by enhancing myomaker mRNA stability
by: Yuxin Huang, et al.
Published: (2024-12-01)

IGF2BP2 orchestrates global expression and alternative splicing profiles associated with glioblastoma development in U251 cells
by: Wenqing Liu, et al.
Published: (2025-01-01)

IGF2BP2: an m6A reader that affects cellular function and disease progression
by: Siyi Liu, et al.
Published: (2025-04-01)

m6A/IGF2BP3-driven serine biosynthesis fuels AML stemness and metabolic vulnerability
by: Feng Huang, et al.
Published: (2025-05-01)

Clinical and prognostic significance of m6A hypomethylation and IGF2BP3 overexpression in gastric cancer: an integrated epigenomic-transcriptomic analysis
by: Xiangchen Hu, et al.
Published: (2025-08-01)

Citrullinated IGF2BP1 promotes rheumatoid synovial aggression via increasing the mRNA stability of SEMA3D
by: Yang Qin, et al.
Published: (2025-01-01)

Emerging trends and global collaboration in Paclitaxel resistance research for breast cancer: a comprehensive bibliometric study
by: Yuxuan Meng, et al.
Published: (2025-08-01)

The biological roles and molecular mechanisms of m6A reader IGF2BP1 in the hallmarks of cancer
by: Li Qiu, et al.
Published: (2025-09-01)

Research note: Detection of IGF2BP2 gene polymorphism associated with growth and reproduction traits of pigeon
by: Yuling Wu, et al.
Published: (2025-03-01)

Two isoforms of the mRNA binding protein IGF2BP2 are generated by alternative translational initiation.
by: Hang T T Le, et al.
Published: (2012-01-01)

Identification of SNPs in the second intron of IGF2BP1 and their Association with growth traits in Nanjiang Yellow goat
by: Shuheng Chen, et al.
Published: (2025-12-01)

Circ_0000284 Is Involved in Arsenite-Induced Hepatic Insulin Resistance Through Blocking the Plasma Membrane Translocation of GLUT4 in Hepatocytes via IGF2BP2/PPAR-γ
by: Shiqing Xu, et al.
Published: (2024-12-01)

Exosome-transmitted LUCAT1 promotes stemness transformation and chemoresistance in bladder cancer by binding to IGF2BP2
by: Yonghao Zhan, et al.
Published: (2025-03-01)

IGF2BP2‐induced circRNF20 facilitates breast cancer cell proliferation via the HuR/CDCA4 axis
by: Shu‐Tao Wu, et al.
Published: (2025-05-01)

IGF2BP3/CTCF Axis–Dependent NT5DC2 Promotes M2 Macrophage Polarization to Enhance the Malignant Progression of Lung Squamous Cell Carcinomas
by: Jifeng Sun, et al.
Published: (2024-11-01)

Curcumin increases the sensitivity of Paclitaxel-resistant NSCLC cells to Paclitaxel through microRNA-30c-mediated MTA1 reduction
by: Yimin Lu, et al.
Published: (2017-04-01)

O-GlcNAcylation of METTL3 drives hepatocellular carcinoma progression by upregulating MCM10 expression in an m6A-IGF2BP3-dependent manner
by: Zhen Chen, et al.
Published: (2025-07-01)

CircATP5C1 promotes triple-negative breast cancer progression by binding IGF2BP2 to modulate CSF-1 secretion
by: Hongbo Liu, et al.
Published: (2025-12-01)

Lactylation‐Driven IGF2BP3‐Mediated Serine Metabolism Reprogramming and RNA m6A—Modification Promotes Lenvatinib Resistance in HCC
by: Yuanxiang Lu, et al.
Published: (2024-12-01)

IGF2BP3 recruits NUDT21 to regulate SPTBN1 alternative polyadenylation and drive ovarian cancer progression
by: Xin Luo, et al.
Published: (2025-04-01)